How to Help Your Patients Save Money on Phenelzine: A Provider's Guide to Savings Programs

For many patients on phenelzine, cost is not a trivial concern. Brand Nardil can exceed $163 for 60 tablets without insurance, and even with coverage, copays can reach $60–$80 per month. For patients with treatment-resistant depression already struggling with employment, daily function, and mental health expenses, phenelzine's cost can become a real barrier to adherence. Here's what prescribers can do to help.

Understanding Phenelzine Pricing

Before advising patients, understand the landscape:

Generic phenelzine (Lupin, Greenstone) 60 tablets: $44–$60 retail; as low as $43.35 with GoodRx coupon

Brand Nardil 60 tablets: $94–$163+ retail

Insurance copay (brand): $60–$80 at most plans (75% coverage rate); generic usually tier 1–2

Medicare Part D: Generic phenelzine on Tier 2 for most plans; Nardil brand may not be covered on all Medicare plans

Prescription Strategy: Generic First

The most impactful prescription-writing change is allowing generic substitution. When you prescribe "phenelzine sulfate 15 mg" without a brand-required (DAW-1) note, pharmacies can dispense the less expensive Lupin or Greenstone generic. For most patients, there is no clinically meaningful difference between the generic and Nardil — they are bioequivalent products with the same active ingredient at the same dose.

In addition to cost savings, the generic may be more accessible during periods when brand Nardil has manufacturing delays.

Prescribe 90-Day Supplies

For stable patients on a consistent phenelzine dose, 90-day prescriptions provide two benefits: lower per-unit cost (most pharmacies and plans charge less per pill for a 90-day supply) and reduced refill frequency (three fill attempts per year instead of twelve). The latter is important given phenelzine's intermittent availability at pharmacies.

Navigating Prior Authorization for Phenelzine

Some insurance plans require prior authorization (PA) for phenelzine, especially the brand. For patients already on phenelzine, PA is generally straightforward — document the diagnosis and prior treatment failures. Key points to include in your PA letter:

Diagnosis (major depressive disorder, panic disorder, social anxiety disorder, or atypical depression)

Documentation of at least two prior antidepressant trials with inadequate response or intolerance

Statement that phenelzine is the medically necessary agent given treatment history

Current clinical response to phenelzine (if already initiated)

Connecting Patients to Drug Discount Programs

For uninsured or underinsured patients, or those whose copay exceeds the coupon price, these programs can help:

GoodRx: Generic phenelzine as low as $43.35 with coupon. Works at most major pharmacy chains. Patients with insurance may sometimes pay less with GoodRx than with their copay — especially for generics.

SingleCare: Nardil brand for approximately $63.25 at participating pharmacies.

NeedyMeds.org and RxAssist.org: Directories of patient assistance programs by drug name. Refer patients with income-based eligibility concerns here first.

State pharmaceutical assistance programs (SPAPs): Many states offer additional assistance for prescription drug costs, particularly for older adults. Check your state's health department website.

Mail-Order Pharmacy as a Cost and Access Solution

For patients with insurance that includes mail-order pharmacy benefits, mail-order is often both cheaper and more reliably stocked than retail pharmacies for phenelzine. Most insurance plan mail-order programs offer a 90-day supply at the price of a 60-day supply. For medications with intermittent retail availability like phenelzine, this is especially valuable.

Refer Patients to medfinder for Pharmacy Searching

Once your patient has a cost-effective prescription strategy in place, they still need to find a pharmacy with phenelzine in stock. Refer them to medfinder.com/providers — medfinder calls pharmacies near your patient and texts them which ones can fill the prescription. This eliminates the phone-call burden for patients and reduces the chances of medication gaps. For a full clinical overview of managing the shortage, see our 2026 provider shortage guide for phenelzine.